Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

CUSIP: G8807B106

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
-135,963
SEC-reported price per share
$17.00
Number of holders
14
Value change
-$2,000,178
Number of buys
8
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
51,428,000

Security key

G8807B106

Report period

Q2 2026

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Weiss Asset Management LP
Disclosed value leader
Madison Avenue Partners, LP
Comparable rows
15/15
Latest evidence
19 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 14% 13D/G row: Weiss Asset Management LP Showing 1-6 of 15 holder rows.

Quick read

Weiss Asset Management LP leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Weiss Asset Management LP's linked filing trail.
Comparable ownership Top 5
Weiss Asset Management LP 14%
Newtyn Management, LLC 8.5%
BlackRock, Inc. 6.5%
Rick E. Winningham 3.4%
Brett A. Grimaud 0.71%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Weiss Asset Management LP
13D/G 3/4/5 13F
10%+ Owner · Company
14%
$149,066,629
7,457,060 shares
$0 23 Mar 2026
Newtyn Management, LLC
13D/G 13F
Company
8.5%
$87,419,000
4,300,000 shares
-$9,299,003 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
6.5%
from 13D/G
$69,728,786
4,296,290 shares
31 Mar 2026
Rick E. Winningham
3/4/5
CHIEF EXECUTIVE OFFICER, Director
3.4%
$28,354,182
1,747,023 shares
20 May 2026
Brett A. Grimaud
3/4/5
SVP, GEN COUNSEL AND SECRETARY
0.71%
$5,893,437
363,120 shares
20 May 2026
Aziz Sawaf
3/4/5
SVP & CHIEF FINANCIAL OFFICER
0.67%
$5,598,587
344,953 shares
20 May 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
379,143
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
171
Q2 2026 holders
14
Holder diff
-157
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .